MX9700174A - Derivados de esterol usados para la regulacion de la meiosis. - Google Patents

Derivados de esterol usados para la regulacion de la meiosis.

Info

Publication number
MX9700174A
MX9700174A MX9700174A MX9700174A MX9700174A MX 9700174 A MX9700174 A MX 9700174A MX 9700174 A MX9700174 A MX 9700174A MX 9700174 A MX9700174 A MX 9700174A MX 9700174 A MX9700174 A MX 9700174A
Authority
MX
Mexico
Prior art keywords
meiosis
regulation
derivatives used
sterol derivatives
sterols
Prior art date
Application number
MX9700174A
Other languages
English (en)
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Hordholm
Henning Thogersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX9700174A publication Critical patent/MX9700174A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Ciertos esteroles los cuales pueden ser extraídos a partir de testículos de toro y a partir de fluidos foliculares humanos y esteroles relacionados químicamente pueden ser usados para regulacion de la meiosis en oocitos y en células germinales masculinas.
MX9700174A 1994-06-23 1995-06-23 Derivados de esterol usados para la regulacion de la meiosis. MX9700174A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (1)

Publication Number Publication Date
MX9700174A true MX9700174A (es) 1997-04-30

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700174A MX9700174A (es) 1994-06-23 1995-06-23 Derivados de esterol usados para la regulacion de la meiosis.

Country Status (26)

Country Link
US (1) US5716777A (es)
EP (1) EP0767798B1 (es)
JP (1) JP3987105B2 (es)
KR (1) KR100408369B1 (es)
CN (1) CN1068333C (es)
AT (1) ATE248852T1 (es)
AU (1) AU694240B2 (es)
BG (1) BG101067A (es)
BR (1) BR9508074A (es)
CA (1) CA2192941C (es)
CZ (1) CZ289407B6 (es)
DE (1) DE69531682T2 (es)
DK (1) DK0767798T3 (es)
ES (1) ES2204955T3 (es)
FI (1) FI117159B (es)
HU (1) HUT76343A (es)
IL (1) IL114294A (es)
IS (1) IS4404A (es)
MX (1) MX9700174A (es)
NO (1) NO314534B1 (es)
PL (1) PL186688B1 (es)
RU (1) RU2194510C2 (es)
SI (1) SI9520077A (es)
SK (1) SK165596A3 (es)
UA (1) UA51622C2 (es)
WO (1) WO1996000235A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996027658A1 (en) * 1995-03-06 1996-09-12 Novo Nordisk A/S Stimulation of meiosis
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
CN1191543A (zh) * 1995-06-23 1998-08-26 诺沃挪第克公司 减数分裂调控化合物
ATE238339T1 (de) * 1996-12-20 2003-05-15 Novo Nordisk As Verbindungen zur regulierung der meiose
CN1260802A (zh) * 1997-05-16 2000-07-19 阿克佐诺贝尔公司 20－芳烷基－5α－孕甾烷衍生物
TR199902873T2 (xx) * 1997-06-04 2000-04-21 Akzo Nobel N.V. Miyozun mod�lasyonu i�in 17�-aliloksi(tiyo)alkil-androstan t�revleri.
EP1042353B1 (en) 1997-12-18 2002-07-17 Akzo Nobel N.V. 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
KR20010043558A (ko) 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
PL344155A1 (en) * 1998-05-13 2001-10-08 Novo Nordisk As Meiosis regulating compounds
CA2333320A1 (en) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
EP1087988A1 (en) * 1998-06-19 2001-04-04 Novo Nordisk A/S Meiosis regulating compounds
DE69903346T2 (de) * 1998-12-11 2003-01-30 Akzo Nobel N.V., Arnheim/Arnhem 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
WO2000047604A1 (en) * 1999-02-10 2000-08-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
ES2258445T3 (es) 1999-02-24 2006-09-01 Novo Nordisk A/S Metodo in vitro para la sincronizacion de la maduracion de ovocitos.
ATE361091T1 (de) * 1999-02-24 2007-05-15 Novo Nordisk As Behandlung von unfruchtbarkeit
WO2000052142A2 (en) * 1999-02-26 2000-09-08 Novo Nordisk A/S Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation
EP1163258B1 (en) * 1999-03-09 2002-12-11 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
AU781994B2 (en) * 1999-09-16 2005-06-23 Novo Nordisk A/S Composition for IVF
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
WO2001062258A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
CZ372596A3 (en) 1997-07-16
IL114294A (en) 2002-09-12
HU9603584D0 (en) 1997-02-28
PL317830A1 (en) 1997-04-28
KR100408369B1 (ko) 2004-04-28
EP0767798B1 (en) 2003-09-03
NO965516L (no) 1997-02-21
HUT76343A (en) 1997-08-28
CA2192941A1 (en) 1996-01-04
DE69531682T2 (de) 2004-07-15
UA51622C2 (uk) 2002-12-16
FI965144A0 (fi) 1996-12-20
DK0767798T3 (da) 2003-12-22
AU694240B2 (en) 1998-07-16
FI965144A (fi) 1997-02-20
US5716777A (en) 1998-02-10
SI9520077A (sl) 1998-06-30
IS4404A (is) 1996-12-23
SK165596A3 (en) 1997-08-06
ES2204955T3 (es) 2004-05-01
DE69531682D1 (de) 2003-10-09
NO314534B1 (no) 2003-04-07
EP0767798A1 (en) 1997-04-16
PL186688B1 (pl) 2004-02-27
CA2192941C (en) 2009-04-14
CN1151164A (zh) 1997-06-04
FI117159B (fi) 2006-07-14
BR9508074A (pt) 1997-08-12
NO965516D0 (no) 1996-12-20
ATE248852T1 (de) 2003-09-15
CN1068333C (zh) 2001-07-11
WO1996000235A1 (en) 1996-01-04
JP3987105B2 (ja) 2007-10-03
AU2734395A (en) 1996-01-19
RU2194510C2 (ru) 2002-12-20
JPH10502060A (ja) 1998-02-24
IL114294A0 (en) 1995-10-31
CZ289407B6 (cs) 2002-01-16
BG101067A (en) 1997-08-29

Similar Documents

Publication Publication Date Title
MX9700174A (es) Derivados de esterol usados para la regulacion de la meiosis.
AU7878998A (en) Meiosis regulating compounds
ATE304845T1 (de) Hautpflaster enthaltend testosteron und gegebenenfalls estrogen
GEP20033067B (en) C-21 Modified Epothilones
GEP20002033B (en) Androstane and Pregnane Series Compounds for Allosteric Modulation of GABA Receptor
AU7753998A (en) Translation system
AR003441A1 (es) Compuestos para regular la meiosis y el uso de los mismos para preparar medicamentos.
BG102881A (en) Method for improving the transplantation after in vitro fertilization
EP1009755A4 (en) STEROID SULFATASE INHIBITORS AND METHODS OF PRODUCING AND USING THE SAME
PL344155A1 (en) Meiosis regulating compounds
ATE526944T1 (de) Selbstbräunungszusammensetzungen die cholesterolsulfat und dha enthalten
AU4012893A (en) Method for inducing the acrosome reaction in human and animal spermatozoa
NO984181D0 (no) Fremgangsmåte for å regulere veksten av mikrober i et vandig system
DE59700064D1 (de) Homogenisierung von Dispersionen
AU6505898A (en) Sperm extender comprising native phosphocaseinate or beta-lactoglobulin, method for preparing same and uses
BR9713762A (pt) Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero.
DE59508647D1 (de) Niedrig dosierte steroidtabletten, die gallussäureester als antioxidans enthalten, verfahren zur herstellung und die verwendung
AU2202301A (en) Cd45 inhibitors
AU2003302747A1 (en) Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
MX9706565A (es) Estimulacion de meiosis.
MX9803681A (es) Inhibicion de la expresion de membrana.
AU7687796A (en) Automatic system and method for regulation of the operation of an automatic valve
FR2722986B1 (fr) Utilisation d'un inhibiteur de la no-synthetase comme medicament destine a reduire la consommation d'alcool ou prevenir l'exces de consommation d'alcool
TW228472B (en) Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
BR9911340A (pt) Compostos, uso de compostos, e, processo de regulação de meiose.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees